source
- Bristol Myers Squibb emphasizes pipeline strength and later-stage partnership focus amid patent cliff concernsBristol Myers Squibb used its latest earnings call to outline how it plans to address an upcoming patent cliff that threatens revenue from several key products. Executives said the company is rely…
- Merck R&D chief says company has outpaced rivals with its sac-TMT cancer platformDean Li, the head of Merck Research Laboratories, said the company believes its sac-TMT cancer program gives it a competitive edge over other firms developing next-generation oncology therapies. T…